Although a correlation between low BDNF levels and/or altered gene regulation and schizophrenia is generally supported in the literature, further studies are necessary to establish the specific mechanisms by which these alterations contribute to schizophrenic pathology and the therapeutic utility of BDNF. This evidence concerns the gene BDNF and schizophrenia.